City Therapeutics Inc(CTY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
CTY
New City Therapeutics Inc
$20.77
+0.00 +0.00%
Oct 23 at 4:00 PM ET (Korea 10/24 05:00)$20.77
+0.00 +0.00%
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 39.99% | Shs Outstand | 50.3M | Perf Week | -7.28% |
| Market Cap | 1.07B | Forward P/E | - | EPS next Y | - | Insider Trans | 1.72% | Shs Float | 31.0M | Perf Month | - |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | 11.39% | Short Float | - | Perf Quarter | - |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | - | Perf Half Y | - |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | - | Perf YTD | -9.7% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -13.02% ($23.88) | Perf Year | - |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 5.16% ($19.75) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 6.39% - | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.7 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | - | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | -1.61% ($21.11) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -1.61% ($21.11) | Rel Volume | 0.62 | Prev Close | $20.77 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -1.61% ($21.11) | Avg Volume(3M) | 0.55M | Price | $20.77 |
| IPO | 2026/10/16 | Option/Short | No/Yes | Trades | 1529 | Volume | 343,849 | Change | - |
Company
City Therapeutics IncCTY | NASD | Biotechnology 🧬 리보핵산 간섭 기술로 질병과 관련된 단백질의 발현을 억제하는 차세대 치료제를 개발하는 임상 단계 바이오테크 기업입니다. 미국에 본사를 두고 있으며 혈전색전 질환, 스타가르트병 1형, 만성질환 빈혈을 겨냥한 파이프라인을 운영합니다. 최근 기업공개로 상장한 소형주입니다.
Quote
Over the past 1 year, on the lower side
13% below its 1-year high.
Now $20.77
52w low$19.7552w high$23.88
52W Range25%
Volume 343,849
Traded less than usual. That is 62% of its average volume.
Has it trended upward long-term? B
Long-term returns are roughly flat
Tap to view numbers
How about dividends?
No dividend
There is no profit to distribute yet.
Who owns it? B
Ownership is about average
Institutions hold 11.4%.
Tap to view numbers
Peer comparison Biotechnology
It ranks #153 of 595 in the industry
Based on market cap of $1B.
SPTX#149 Seaport Therapeutics Inc $1B PER - 
IMTX#150 Immatics N.V $1B PER - 
VOR#151 Vor Biopharma Inc $1B PER - 
REPL#152 Replimune Group Inc $1B PER - CTY#153 City Therapeutics Inc $1B PER - Reads on this stock 1 posts
FAQ
FAQ
What kind of company is CTY?
CTY belongs to the Healthcare sector and operates in the Biotechnology industry.
What is the market cap of CTY?
The market cap of CTY is approximately $1.1B, ranking 2,524 within its sector.
What is the 52-week high and low for CTY?
CTY has recorded a 52-week high of $23.88 and a low of $19.75.
Briefs · earnings · signals, first Telegram · KakaoTalk channels
